Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3SJW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,969
Award facts
- Contract value 100% obligated
- $5,968.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,968.71 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 29, 2025, with completion expected by December 30, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's existing contract vehicle with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center for federal medical procurement.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's role in the DLA's Pharmaceutical Prime Vendor Global Program demonstrates its capability to support Defense Health Agency operations and other government healthcare systems on a competitive, open-market basis. Ondansetron is a commonly used antiemetic medication within military medical supply chains, supporting patient care across military treatment facilities and deployed medical operations.
Quick answers
Who was awarded contract SPE2DR26F3SJW?
SPE2DR26F3SJW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F3SJW worth?
The government has obligated $5,969 on SPE2DR26F3SJW.
Is contract SPE2DR26F3SJW an order under another contract?
Yes. SPE2DR26F3SJW is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SJW competed?
The extent of competition for SPE2DR26F3SJW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award